PERCEPTIVE ADVISORS LLC's Q3 2026 13F: 23 new positions, 25 exits

Form 13F-HR for the quarter ended Sep 30, 2026 · filed Nov 16, 2026 · 99 reported positions · accession 0001012975-26-001063

What changed this quarter

PERCEPTIVE ADVISORS LLC's changes in reported equity positions, Q3 2026
Activity Security Weight before Weight now Change Shares Shares %
New FREENOME INC (FRNM) — 3.7% +3.7 pts +12.61M sh new
Exited NUVALENT INC (NUVL) 3.0% — −3.0 pts −1.58M sh −100%
Exited APOGEE THERAPEUTICS INC (APGE) 2.7% — −2.7 pts −1.31M sh −100%
Reduced SPYRE THERAPEUTICS INC (SYRE) 6.0% 5.5% −0.5 pts −1.04M sh −24%
Increased AMYLYX PHARMACEUTICALS INC (AMLX) 2.3% 5.8% +3.4 pts +2.24M sh +27%
New WATERS CORP (WAT) — 1.1% +1.1 pts +135K sh new
Reduced ROIVANT SCIENCES LTD (ROIV) 4.5% 4.5% 0.0 pts −1.57M sh −19%
Reduced BIOGEN INC (BIIB) 0.9% 0.1% −0.8 pts −248K sh −90%
Reduced ASCENDIS PHARMA A/S (ASND) 4.8% 4.2% −0.7 pts −192K sh −17%
New OPUS GENETICS INC (OCUP) — 0.8% +0.8 pts +9M sh new
Reduced UNITEDHEALTH GROUP INC (UNH) 0.8% 0.1% −0.7 pts −107K sh −91%
Exited IONIS PHARMACEUTICALS INC (IONS) 0.7% — −0.7 pts −566K sh −100%
New LAKEFRONT BIOTHERAPEUTICS NV (LKFT) — 0.7% +0.7 pts +1.24M sh new
New ABBOTT LABORATORIES (ABT) — 0.6% +0.6 pts +345K sh new
Exited JAZZ PHARMACEUTICALS PLC (JAZZ) 0.6% — −0.6 pts −170K sh −100%
New BLOSSOMHILL THERAPEUTICS INC (BLSM) — 0.6% +0.6 pts +1.81M sh new
Exited SIONNA THERAPEUTICS INC (SION) 0.6% — −0.6 pts −905K sh −100%
Exited CORCEPT THERAPEUTICS INC (CORT) 0.5% — −0.5 pts −398K sh −100%
Reduced IMMUNOVANT INC (IMVT) 0.8% 0.3% −0.5 pts −838K sh −62%
Exited DAMORA THERAPEUTICS INC (GLTO) 0.5% — −0.5 pts −1.22M sh −100%
Exited CHARLES RIV LABS INTL INC (CRL) 0.5% — −0.5 pts −140K sh −100%
New MINIMED GROUP INC (MMED) — 0.5% +0.5 pts +1.32M sh new
Increased NURIX THERAPEUTICS INC (NRIX) 1.6% 2.4% +0.8 pts +1.05M sh +24%
Reduced RELAY THERAPEUTICS INC (RLAY) 4.1% 4.3% +0.2 pts −1.38M sh −10%
Exited AXSOME THERAPEUTICS INC. (AXSM) 0.5% — −0.5 pts −118K sh −100%
Reduced ADAPTIVE BIOTECHNOLOGIES COR (ADPT) 0.4% 0.2% −0.2 pts −805K sh −66%
Reduced DYNE THERAPEUTICS INC (DYN) 0.9% 0.4% −0.5 pts −1.42M sh −53%
Reduced ORUKA THERAPEUTICS INC (ORKA) 2.0% 1.7% −0.3 pts −273K sh −20%
New SEPTERNA INC (SEPN) — 0.4% +0.4 pts +567K sh new
New ENLIVEN THERAPEUTICS INC (ELVN) — 0.4% +0.4 pts +463K sh new
Exited TENAX THERAPEUTICS INC (TENX) 0.4% — −0.4 pts −1.7M sh −100%
Reduced PROTAGONIST THERAPEUTICS INC (PTGX) 1.9% 2.2% +0.3 pts −145K sh −15%
Reduced REVOLUTION MEDICINES INC (RVMD) 1.5% 1.7% +0.1 pts −94,500 sh −18%
New YARROW BIOSCIENCE INC (YARW) — 0.3% +0.3 pts +813K sh new
Exited INTUITIVE SURGICAL INC (ISRG) 0.3% — −0.3 pts −51,884 sh −100%
Reduced TANGO THERAPEUTICS INC (TNGX) 1.6% 1.3% −0.4 pts −684K sh −20%
Exited CONTINEUM THERAPEUTICS INC (CTNM) 0.3% — −0.3 pts −1.26M sh −100%
New SCRIBE THERAPEUTICS INC (SCTX) — 0.3% +0.3 pts +920K sh new
Reduced ZYMEWORKS INC (ZYME) 1.7% 1.8% +0.1 pts −637K sh −15%
Reduced NUVECTIS PHARMA INC (NVCT) 0.3% 0.1% −0.2 pts −760K sh −76%
Reduced DANAHER CORP DEL (DHR) 0.4% 0.2% −0.1 pts −70,000 sh −54%
Exited OMADA HEALTH INC (OMDA) 0.3% — −0.3 pts −786K sh −100%
New GRAIL INC (GRAL) — 0.3% +0.3 pts +96,911 sh new
Reduced IRHYTHM HOLDINGS INC (IRTC) 0.4% 0.2% −0.2 pts −110K sh −49%
Reduced TRAVERE THERAPEUTICS INC (TVTX) 3.3% 3.9% +0.6 pts −210K sh −6%
New VERADERMICS INC (MANE) — 0.2% +0.2 pts +97,000 sh new
New ENTERA BIO LTD (ENTX) — 0.2% +0.2 pts +3.43M sh new
Reduced EDGEWISE THERAPEUTICS INC (EWTX) 2.8% 3.2% +0.4 pts −236K sh −5%
Exited OSCAR HEALTH INC (OSCR) 0.2% — −0.2 pts −400K sh −100%
Exited BOSTON SCIENTIFIC CORP (BSX) 0.2% — −0.2 pts −250K sh −100%

The 50 largest of 100 changes, by size of the trade. Full holdings for this quarter.

Reported by the fund in its Form 13F filed with the SEC; holdings are as of the quarter-end report date and may have changed since. For informational purposes only — not investment advice or a recommendation to buy or sell any security. FilingExplorer is not affiliated with or endorsed by this fund. How this brief is compiled

Top 10 positions — 52.2% of the equity book

Changes in the top 10 this quarter: AMLX entered · FRNM entered · KARD left · NUVL left

# Security Weight before Weight now
1 PRAXIS PRECISION MEDICINES I (PRAX) 10.6% 11.1%
2 AMYLYX PHARMACEUTICALS INC (AMLX) 2.3% 5.8% Entered the top 10
3 SPYRE THERAPEUTICS INC (SYRE) 6.0% 5.5%
4 CELCUITY INC (CELC) 5.2% 4.7%
5 RHYTHM PHARMACEUTICALS INC (RYTM) 4.5% 4.5%
6 ROIVANT SCIENCES LTD (ROIV) 4.5% 4.5%
7 RELAY THERAPEUTICS INC (RLAY) 4.1% 4.3%
8 ASCENDIS PHARMA A/S (ASND) 4.8% 4.2%
9 TRAVERE THERAPEUTICS INC (TVTX) 3.3% 3.9%
10 FREENOME INC (FRNM) 0.0% 3.7% Entered the top 10
— KARDIGAN INC (KARD) 3.0% 2.3% Left the top 10
— NUVALENT INC (NUVL) 3.0% 0.0% Left the top 10

Weights are each position's reported value as a share of the fund's reported equity positions (options and principal-amount holdings excluded).

Option positions (puts and calls)

Reported separately from the positions above. The value a 13F reports for an option is that of the underlying shares, not the option itself.

Activity Security Type Shares before Shares now Reported value
Increased MODERNA INC (MRNA) Put 1M 1.4M $270M
New SELLAS LIFE SCIENCES GROUP I (SLS) Call 0 3M $36.9M
Exited CAPRICOR THERAPEUTICS INC (CAPR) Call 1M 0 $0
Increased EYEPOINT INC (EYPT) Put 2M 3.5M $11.4M
Reduced SPDR SERIES TRUST (XBI) Put 300K 200K $31.5M
Exited CAPRICOR THERAPEUTICS INC (CAPR) Put 500K 0 $0
Increased SELLAS LIFE SCIENCES GROUP I (SLS) Put 1.5M 2.5M $30.8M
New BIOHAVEN LTD (BHVN) Put 0 200K $2.67M
New EYEPOINT INC (EYPT) Call 0 725K $2.37M
Increased NEWAMSTERDAM PHARMA COMPANY (NAMS) Put 500K 600K $14.6M